{
    "address": "Scheelevagen 15",
    "city": "Lund",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W989BS105",
    "description": "Ziccum AB engages in the development and commercialization of patented spray drying technology, LaminarPace. The company is headquartered in Lund, Skane. The company went IPO on 2018-10-25. LaminarPace is a CE-marked instrument for drying small amounts of drug substances with low losses. Ziccum AB intends to use its LaminarPace technology to begin creating new versions of dry powder therapies.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Pharmaceuticals",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Pharmaceuticals",
    "gsector": "Health Care",
    "gsubind": "Pharmaceuticals",
    "ipo": "2018-10-25",
    "isin": "SE0011415595",
    "logo": "",
    "marketCapitalization": 172.9116,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Biological Product (except Diagnostic) Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Ziccum AB",
    "phone": "4672246781462.0",
    "sedol": "BGNKK20",
    "shareOutstanding": 9.6062,
    "state": "SKANE",
    "ticker": "ZICC.ST",
    "weburl": "http://ziccum.com/"
}